Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This review evaluates dihydrotestosterone's role in androgenic alopecia and proposes a model suggesting that chronic scalp tension and inflammation contribute to hair follicle miniaturization, identifying fibrosis, calcification, and tension as treatment targets.

This review discusses the evaluation and management of male baldness and related conditions, but reports no new clinical results.

This study examined the follicular unit density in the scalp and beard donor areas of Indian men undergoing hair restoration surgery, reporting mean densities of 78.2/cm² and 49.7/cm² respectively, and proposed guidelines for safe follicular unit extraction.

This review proposes that inconsistent findings in androgenic alopecia research are due to variable biopsy location, hair diameter diversity, and hair follicle miniaturization, and suggests ways to improve study methods.

This review discusses recent advances in understanding the pathophysiology and molecular mechanisms of androgenetic alopecia in males, females, and children, but reports no new clinical results.

Hair loss caused by genetics and hormones; more research needed for treatments.

Treatments for hair loss include hormone modifiers, minoxidil, and hair transplant surgery.

This study found that testosterone and 5α-dihydrotestosterone induced apoptosis in dermal papilla cells from nonbalding scalp regions, suggesting a high androgen stimulus can trigger cell death related to androgenetic alopecia.

This study found that the DKK3-CKAP4 signaling axis is involved in fibroimmune remodeling in androgenetic alopecia and that targeting this pathway may restore a regenerative hair follicle environment, offering a potential therapeutic strategy to counteract hair follicle miniaturization.

Estetrol may help prevent hair loss and support hair growth in women.

This study found that androgenetic alopecia can affect the occipital region in men with advanced stages of the condition.

In this study, autologous stem cell therapy was associated with a 29% increase in hair density in androgenetic alopecia patients over six months, suggesting potential for further investigation.

This article discusses disruptions in hair cycle dynamics and follicular miniaturization associated with patterned hair loss, emphasizing androgen-related changes, and reports no clinical findings.

This article discusses the role of hair restoration surgeons in balancing various aspects of their practice, but it reports no new results.

The occipital scalp is affected in advanced hair loss, so it shouldn't be used as a control.

This study suggests that bio-nanovesicles, such as exosomes and microvesicles, may enhance skin and hair follicle regeneration by modulating key signaling pathways, potentially overcoming the limitations of conventional treatments for alopecia and chronic skin diseases.

This review discusses the complex genetic factors contributing to androgenetic alopecia, highlighting the variability in genetic risk across different populations and the emerging understanding of personalized treatment strategies, but reports no new clinical findings.

This review addresses the causes, mechanisms, and treatment options for the most common non-scarring alopecias in females, including telogen effluvium, alopecia areata, and female pattern hair loss.

In this review, an association was reported between early-onset androgenetic alopecia and several health conditions like obesity and cardiovascular disease, with genetic and therapeutic research ongoing to improve treatment.

This review discusses how dermoscopy enhances diagnostic accuracy in hair and scalp disorders, particularly distinguishing between conditions such as cicatricial and non-scarring alopecia, and offers insights into its practical uses in hair transplantation; it reports no new clinical results.

TrichoScan effectively measures hair growth improvements in people using minoxidil.

This article discusses various issues and controversies in hair transplantation, including ethical considerations, the debate between follicular unit transplantation and excision, the concept of a safe donor area, the use of platelet-rich plasma, and the minimum qualifications needed for practitioners.

This review discusses the potential of cell therapies using dermal papilla and dermal sheath cells for androgenetic alopecia, highlighting their ability to reverse hair follicle miniaturization but not yet achieving significant cosmetic efficacy in trials.

Androgenetic alopecia treatments focus on reducing hair loss by targeting hormones, with new therapies showing promise but needing more research.

This paper identifies challenges in diagnosing alopecia variants, emphasizing the importance of pathologists understanding hair follicle histology, biopsy types, and collaborating with dermatologists to improve diagnostic accuracy.

This article reviews the epidemiology of desmoplastic melanoma and reports no new clinical findings, emphasizing higher risks in chronically sun-exposed older males.

In this viewpoint, researchers discussed the possible role of the developmental origin of scalp dermis in influencing the specific pattern of hair follicle miniaturization seen in male pattern hair loss, noting that frontal follicles are more susceptible while occipital follicles remain largely terminal.

This review discusses androgenetic alopecia and reports no clinical findings; the authors highlight a need for further research.

This study found that molecular differences in paracrine factors between balding and non-balding hair follicles may enhance understanding of androgen action in hair disorders and potentially inform better treatments.

This study found that dihydrotestosterone alters the balance of Wnt pathway regulators in dermal papilla cells, hindering hair follicle stem cell differentiation and contributing to hair follicle miniaturization.